Success rates. Embryo quality. The next treatment option. But this week’s fertility news highlights something else many patients are quietly struggling with: Decision fatigue. IVF patients are being asked to make increasingly complex decisions One of the biggest fertility stories this week involved renewed warnings from the UK fertility regulator about IVF add-ons. Add-ons are optional treatments or technologies offered alongside standard IVF care. These can include: embryo glue immune...

If you’ve been around fertility care for a while, you’ll know the conversation often centres on science: embryo grading, testing, protocols, success rates. But this week’s Australian headlines point to something else shaping IVF just as strongly: trust and cost. Trust is a clinical issue Monash IVF’s recent financial results have been widely reported, alongside commentary that links market share and patient demand to the reputational fallout from high-profile incidents. That’s not “business...

Want some pre-prepared answers to the inappropriate questions you know you're going to be asked at Christmas-time? Read on!